EFFECT OF DEXMEDETOMIDINE ON ANAESTHESIA AND ANALGESIA REQUIREMENT AND RECOVERY CHARACTERISTICS DURING BISPECTRAL INDEX GUIDED ANAESTHESIA FOR NEUROSURGERY CASES

EFFECT OF DEXMEDETOMIDINE ON ANESTHESIA AND ANALGESIA REQUIREMENT DURING BISPECTRAL INDEX GUIDE ANAESTHESIA FOR NEUROSURGERY

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/10/037597

Enrollment

Registered

2021-10-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Dexmedetomidine: To be given during induction of anesthesia and see for haemodynamics, 0.5mcg/kg IV Control Intervention1: Fentanyl: To be given during induction of anaesthesia and see

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA grade I & II 2. Ages between 18 to 60 years of either gender. 3. Haemodynamically stable patients with normal laboratory investigations. 4. Patients willing and giving consent to be a part of the study.

Exclusion criteria

Exclusion criteria: 1. Patients not willing to be a part of the study. 2. Patients on pain perception modifying drugs. 3. Patients with known sensitivity to any of the drugs under study.

Design outcomes

Primary

Measure	Time frame
EFFECT OF DEXMEDETOMIDINE ON ANAESTHESIA AND ANALGESIA REQUIREMENT AND RECOVERY CHARACTERISTICS DURING BISPECTRAL INDEX GUIDED ANAESTHESIA FOR NEUROSURGERY â??A RANDOMISED CLINICAL TRIALTimepoint: 6 months	—

Secondary

Measure	Time frame
Depth of anaesthesia as per Bispectral index â??guided anaesthesia. Adverse effects if any.Timepoint: 3hours	—

Countries

India

Contacts

Public ContactDr Preeti Raj

Dr D Y Patil Medical College Hospital and Research Centre

v.charri@yahoo.com7251888789

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026